There was a problem loading this presentation. You may not have permission to view it.

You do not have permission to view this presentation.

Treatment of CTEPH

OK

An error occurred while loading this content.

Please refresh the page to try again.

Refresh Now
>>
<<
 
You previously started this content
Replay
Resume
 
Login or join to view
Click to Play
 

Treatment of CTEPH

Prof. Dr. H.-Ardeschir Ghofrani
Head, Pulmonary Hypertension, University Clinic Giessen, Professor for Pulmonary Vascular Medicine, University Giessen Head of Pneumology, Bad Nauheim, University Clinic Giessen and Marburg GmbH, Kerckhoff Klinik Bad Nauheim, Department of Medicine, Imperial College London, Excellence Cluster Cardio-Pulmonary System (ECCPS), German Center for Lung Research (DZL)
 
 

The chronic thromboembolic pulmonary hypertension is the so-called WHO group 4 of mulmonal types of hypertension, a sub-group that consists of different underlying diseases. Foremost here, however, is chronic thromboembolic pulmonary hypertension on the basis of recurring pulmonary embolisms. This short presentation makes the CTEPH treatment algorithm a subject of discussion as well as the CHEST-study and elucidates the Hybrid-BPA with the help of videos.